Evidence map›Paper›PMID 31431793›Full record

Observational studyThe Journal of thoracic and cardiovascular surgery2019

Predialysis coronary revascularization and postdialysis mortality.

Abduzhappar Gaipov, Miklos Z Molnar, Praveen K Potukuchi, Keiichi Sumida, Robert B Canada, Oguz Akbilgic, Kairat Kabulbayev, Zoltan Szabo, Santhosh K G Koshy, Kamyar Kalantar-Zadeh and 1 more

Open access · bronzeAbstract readComparative StudyObservational StudyVideo-Audio Media
In one paragraph

Observational study in The Journal of thoracic and cardiovascular surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Coronary artery bypass graft surgeryTherapeutic advances in chronic disease · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Abduzhappar GaipovDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Miklos Z MolnarDivision of Transplant Surgery, Methodist University Hospital Transplant Institute, Memphis, TN, USA.
Praveen K PotukuchiDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Keiichi SumidaDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Robert B CanadaDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Oguz AkbilgicCenter for Biomedical Informatics, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, United States.
Kairat KabulbayevDepartment of Nephrology, Kazakh National Medical University, Almaty, Kazakhstan.
Zoltan SzaboDepartment of Cardiothoracic Surgery and Anesthesia, Linköping University Hospital, Linkoping, Sweden.
Santhosh K G KoshyDivision of Cardiology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Kamyar Kalantar-ZadehHarold Simmons Center for Chronic Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California-Irvine, Orange, CA, United States.
Csaba P KovesdyDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
University of Tennessee Health Science Center · USKazakh National Medical University · KZLinköping University · SESemmelweis University · HUUniversity of California, Irvine · US

Funding

Transition of Care in CKD (TC-CKD)U01DK102163 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI JACOBSEN, STEVEN J, KALANTAR-ZADEH, KAMYAR · 2014 to 2018
$2.8M
HSRD VA SDR 02-237NIDDK NIH HHS U01 DK102163
6 · The paper itself

Abstract

Objectives: Coronary artery bypass grafting (CABG) is associated with better survival than percutaneous coronary intervention (PCI) in patients with mild-to-moderate chronic kidney disease (CKD) and End-Stage Renal Disease (ESRD). However, the optimal strategy for coronary artery revascularization in advanced CKD patients who transition to ESRD is unclear. Methods: We examined a contemporary national cohort of 971 US veterans with incident ESRD, who underwent first CABG or PCI up to 5 years prior to dialysis initiation. We examined the association of a history of CABG versus PCI with all-cause mortality following transition to dialysis, using Cox proportional hazards models adjusted for time between procedure and dialysis initiation, socio-demographics, comorbidities and medications. Results: 582 patients underwent CABG and 389 patients underwent PCI. The mean age was 66±8 years, 99% of patients were male, 79% were white, 19% were African Americans, and 84% were diabetics. The all-cause post-dialysis mortality rates after CABG and PCI were 229/1000 patient-years (PY) [95% CI: 205-256] and 311/1000PY [95% CI: 272-356], respectively. Compared to PCI, patients who underwent CABG had 34% lower risk of death [multivariable adjusted Hazard Ratio (95% CI) 0.66 (0.51-0.86), p=0.002] after initiation of dialysis. Results were similar in all subgroups of patients stratified by age, race, type of intervention, presence/absence of myocardial infarction, congestive heart failure and diabetes. Conclusion: CABG in advanced CKD patients was associated lower risk of death after initiation of dialysis compared to PCI.

Indexed as

AgedCoronary Artery BypassCoronary Artery DiseaseFemaleHumansIncidenceKidney Failure, ChronicMaleMiddle AgedPercutaneous Coronary InterventionRenal DialysisRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment Outcomeall-cause mortalitychronic kidney diseasecoronary artery bypass graftingend-stage renal diseasepercutaneous coronary interventions

Identifiers

PMID31431793
PMCPMC6701475
OpenAlexW2892740324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.